Pressure BioSciences Aims to Raise $1.2M in Private Placement | GenomeWeb

NEW YORK (GenomeWeb News) – Pressure BioSciences today said that it has reached an agreement with investors on the first half of a targeted $1.2 million private placement.

The firm said that 17 investors have agreed to purchase Pressure Bio shares for approximately $600,000 in the initial tranche. The investors include Pressure Bio's board of directors, officers of the firm, all members of the prior board of directors, and several existing investors in the company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.